Digital oncology platform Jasper Health is partnering with employer-focused third-party administration platform Covet Health to offer its cancer care support services to Covet's members.
Jasper Health provides a hybrid digital, but human-led, cancer care platform for patients and providers that offers care navigation and guidance, data insights, remote patient monitoring capabilities, cancer...
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multiyear strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology.
Pfizer will leverage Tempus' library of de-identified data to accelerate therapeutic development in oncology. It will also use Tempus' AI-driven companion diagnostic offerings...
Oncology patients saved both time and travel costs when utilizing telehealth services, reducing the cost burden associated with cancer care, according to a study published in JAMA Network Open.
The economic evaluation, conducted through Moffitt Cancer Center, estimated patient cost savings due to telehealth, including the cost of travel and potential loss of productivity due to the medical visit...
Medical AI startup Qritive has pooled $7.5 million in a funding round led by MassMutual Ventures and supported by Enterprise Singapore's investment arm SEEDS Capital and Exfinity Venture Partners.
WHAT IT DOES
Founded in 2017, the Singapore-headquartered company offers diagnostic support solutions that provide fast and accurate pathological interpretations "within seconds." Its digital pathology...
Roche, one of the largest pharma companies in Europe, has been expanding its ambitions in genomic and personalized medicine, emerging practices that use information about a patient's genetic profile or proteins to prevent, diagnose or treat disease.
Dr. Oliver Bleck, area head of Europe South at Roche, joined MobiHealthNews to discuss Roche's advancements in oncology, its current work in...
Australian researchers have developed an online tool to help cancer survivors manage their fears of cancer recurrence.
A research team has made a digital adaptation of a therapist-delivered treatment called ConquerFear, which was originally developed by the Psycho-Oncology Co-operative Research Group, a national cancer clinical trial group under the University of Sydney. The treatment has been...
Researchers from the Indian Institute of Technology in Madras have come up with a new AI prediction tool that can detect cancer-causing genes in individuals.
WHAT IT DOES
Dubbed PIVOT, the AI tool is based on a prediction model that uses information on mutations, expression of genes, and copy number variation in genes and perturbations in the biological network due to an altered gene expression....
Karkinos Healthcare, a technology-driven cancer care platform in India, has entered into a strategic partnership with American oncology diagnostics firm C2i Genomics to promote AI-enabled cancer monitoring in the country.
According to a press statement, their partnership will expand minimal residual disease (MRD) monitoring across Karkinos' network using C2i Genomics' whole-genome analysis...
Weekly electronic symptom-tracking surveys improved physical function, symptom control and health-related quality of life among cancer patients, according to a study published in JAMA.
In a randomized trial that included 52 practices and 1,191 patients receiving treatment for metastatic cancer, researchers found statistically significant improvements in secondary outcomes like function and...
Mental health EHR Osmind scored $40 million in a Series B funding round led by DFJ Growth.
Other participants include Susa Ventures, General Catalyst, Future Ventures, Tiger Global, Pear VC and angels Lachy Groom, Brent Saunders, Helena Goodman and Ariel Katz.
Osmind offers an EHR tailored to clinicians and researchers using and studying ketamine and other psychedelics, as well as transcranial...
_8_32.jpeg?itok=mU58uQog "A piggy bank next to a stethoscope and a pile of coins")
